Clin Med
-
There is a broad consensus that international trade in goods is beneficial, providing of course that it is fair. Yet not all things that are traded are goods. Some can more appropriately be considered as 'bads'. ⋯ However, there are other things that are legitimately traded where restrictions may be needed, such as alcohol. Global trade is simply a means to an end. The ultimate goal must include better health for all.
-
Myocardial infarction (MI) and stroke are the first and third leading causes of death in the U. S. A. accounting for more than 1 in 3 deaths per annum. ⋯ Human umbilical cord blood (hUCB) appears to be a logical candidate as a source of cells. hUCB is readily available, and presents little ethical challenges. Stem cells derived from hUCB are multipotent and immunologically naive. Here is a critical literature review of the beneficial effects of hUCB cell therapy in preclinical trials.
-
There is now no dispute about climate change: it is happening, and human activity is driving it. Each day, the threat this poses becomes clearer--threatening our civilisation and also the survival of our species. ⋯ But we can all respond to make the difference. And the time to do so is now.
-
Comparative Study
Should we implement 'opt-out' HIV testing for patients with lymphoma?
Patients with HIV are dying due to late diagnosis and physicians are being encouraged to increase HIV testing. The uptake of opt-in HIV screening for 113 lymphoma patients was audited at University College London Hospital. Of the 113 patients, 46 were not tested (41%). Previous research in the antenatal setting suggests that adopting opt-out screening would increase testing rates.